The ROE as of December 2025 (TTM) for Citius Oncology, Inc. (CTOR) is -68.38%

According to Citius Oncology, Inc.’s latest financial reports and current stock price. The company's current ROE is -68.38%. This represents a change of 295.42% compared to the average of -17.29% of the last 4 quarters.

Citius Oncology, Inc. (CTOR) Historical ROE (quarterly & annually)

How has CTOR ROE performed in the past?

The mean historical ROE of Citius Oncology, Inc. over the last ten years is -27.63%. The current -68.38% ROE has changed 147.44% with respect to the historical average. Over the past ten years (40 quarters), CTOR's ROE was at its highest in in the June 2023 quarter at 0.89%. The ROE was at its lowest in in the March 2025 quarter at -21.70%.

Citius Oncology, Inc. (CTOR) ROE by Quarter and Year

Discovering the peaks and valleys of Citius Oncology, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Citius Oncology, Inc. (CTOR) Average ROE

How has CTOR ROE performed in the past?

The current ROE of Citius Oncology, Inc. (CTOR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Citius Oncology, Inc. (CTOR) ROE vs. Peers

How is CTOR’s ROE compared to its peers?

Citius Oncology, Inc.’s ROE is less than Scilex Holding Company (180.51%), greater than Actuate Therapeutics Inc (-2924.50%), greater than Forte Biosciences, Inc. (-75.64%), greater than Spero Therapeutics, Inc. (-125.91%), greater than Applied Therapeutics, Inc. (-65.63%), less than Vor Biopharma Inc. (274.58%), less than Seres Therapeutics, Inc. (15.31%), greater than Fate Therapeutics, Inc. (-56.63%), less than LENSAR, Inc. (5.18%), less than Owlet, Inc. (246.75%),

Build a custom stock screener for Citius Oncology, Inc. (CTOR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Citius Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Citius Oncology, Inc. (CTOR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Citius Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.